STERIS plc Cash and Cash Equivalents, Period Increase (Decrease)
STERIS plc (STE) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$21.40 million for the 9-month period ending 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-02-10
- STERIS plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$26.31M, a 275.55% decline year-over-year.
- STERIS plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$12.53M.
- STERIS plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $17.43M, a 2.61% increase year-over-year.
- STERIS plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$4.27M.
- STERIS plc cash and cash equivalents, period increase (decrease) for fiscal 2019 was $19.10M.
- STERIS plc cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$81.38M, a 338.82% decline from fiscal 2017.
- STERIS plc cash and cash equivalents, period increase (decrease) for fiscal 2017 was $34.08M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$26.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$38.84M derived: sum of 2 quarters · filed 2020-02-10 | -$21.40M 10-Q · filed 2020-02-10 | -$25.68M derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-09-30 | -$12.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $4.90M 10-Q · filed 2019-11-07 | $630.00K derived: sum of 3 quarters · filed 2019-11-07 | $15.62M derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-06-30 | $17.43M 10-Q · filed 2019-08-07 | $13.16M derived: sum of 2 quarters · filed 2019-08-07 | $28.15M derived: sum of 3 quarters · filed 2020-02-10 | $19.54M derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-03-31 | -$4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-30 | $10.71M derived: sum of 2 quarters · filed 2020-02-10 | $2.11M derived: sum of 3 quarters · filed 2020-02-10 | $19.10M 10-K · filed 2019-05-30 |
| 2018-12-31 | $14.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $6.38M derived: sum of 2 quarters · filed 2020-02-10 | $23.37M 10-Q · filed 2020-02-10 | |
| 2018-09-30 | -$8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $8.39M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $16.99M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | -$81.38M 10-K · filed 2019-05-30 | |||
| 2017-03-31 | $34.08M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |